Scleroderma Esophageal Involvement

Overview


Plain-Language Overview

Scleroderma Esophageal Involvement is a condition where the esophagus, the tube that carries food from the mouth to the stomach, becomes affected by a disease called scleroderma. This disease causes the skin and connective tissues to become thick and stiff, and it can also affect internal organs like the esophagus. When the esophagus is involved, it can lead to problems with swallowing and cause heartburn or acid reflux. The muscles in the lower part of the esophagus may weaken, making it hard for food to move down properly. This can result in discomfort and difficulty eating. The condition mainly affects the digestive system and can impact nutrition and quality of life.

Clinical Definition

Scleroderma Esophageal Involvement is a manifestation of systemic sclerosis characterized by fibrosis and atrophy of the esophageal smooth muscle, primarily affecting the distal two-thirds of the esophagus. The underlying mechanism involves autoimmune-mediated vascular injury and excessive collagen deposition leading to esophageal dysmotility and lower esophageal sphincter (LES) incompetence. This results in impaired peristalsis and gastroesophageal reflux disease (GERD). Clinically, patients present with dysphagia, heartburn, and potential complications such as strictures or Barrett esophagus. The condition is significant due to its impact on nutritional status and risk of aspiration. It is commonly seen in patients with limited or diffuse cutaneous systemic sclerosis.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.